Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 1, 2006, Pages 84-90

  Yeh, Wen Ting ^a   Chen, Rong Fu ^b   Wang, Lin ^a   Liu, Jien Wei ^c   Shaio, Men Fang ^d   Yang, Kuender D ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d KUANG TIEN GENERAL HOSPITAL   (Taiwan)

Author keywords

Cytokines; Dengue hemorrhagic fever (DHF); Secondary dengue 2 (DEN 2) infection; Virus load

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 10;

ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; EPIDEMIC; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPERINFECTION; TAIWAN; THROMBOCYTE COUNT; VIRUS IMMUNITY; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANTIBODIES, VIRAL; CYTOKINES; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; HUMANS; INTERLEUKIN-10; TAIWAN; VIRAL LOAD;

EID: 33748595585     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00127.x     Document Type: Article

References (42)

1. Anantapreecha S, Chanama S, A-nuegoonpipat A, Naemkhunthot S, Sa-Ngasang A, Sawanpanyalert P & Kurane I (2005) Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. Epidemiol Infect 133: 503-507.
2. Castleberry JS & Mahon CR (2003) Dengue fever in the Western Hemisphere. Clin Lab Sci 16: 34-38.
3. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R, Pacsa AS, Younis OI & Azizieh F (1999) Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 59: 335-340.
4. Chaturvedi UC, Agarwal R, Elbishbishi EA & Mustafa AS (2000) Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183-188.
5. Chen WJ, Chen SL, Chien LJ, Chen OC, King OC, Harn MR, Hwang KP & Fang JH (1996) Silent transmission of the dengue virus in southern Taiwan. Am J Trop Med Hyg 55: 12-16.
6. Chen RF, Yeh WT, Yang MY & Yang KD (2001) A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol Med Microbiol 30: 1-7.
7. Chen RF, Liu JW, Yeh WT,Wang L, Chang JC, Yu HR, Cheng JT & Yang KD (2005) Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 44: 43-50.
8. Clarke T (2000) Dengue virus: break-bone disease. Nature 416: 672-674.
9. Cousens LP, Peterson R, Hsu S, Dorner A, Altman JD, Ahmed R & Biron CA (1999) Two roads diverged: interferon alpha/beta-and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection. J Exp Med 189: 1315-1328.
10. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS & Graham BS (2002) The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 168: 2944-2952.
11. Ferguson N, Anderson R & Gupta S (1999) The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci USA 96: 790-794.
12. Gagnon SJ, Mori M, Kurane I, Green S, Vaughn DW, Kalayanarooj S, Suntayakorn S, Ennis FA & Rothman AL (2002) Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections. J Med Virol 67: 41-46.
13. Guzman MG (2005) Deciphering dengue: the Cuban experience. Science 309: 1495-1497.
14. Guzman MG, Kouri G & Halstead SB (2000) Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet 355: 1902-1903.
15. Halstead SB (2000) Dengue fever/dengue hemorrhagic fever. Nelson Textbook of Pediatrics, 16th edn (Behrman RE, Kliegman RM & Jenson HB, eds), pp. 1005-1007. W.B. Saunders Co, Philadelphia, USA.
16. Harn MR, Chiang YL, Tian MJ, Chang YH & Ko YC (1993) The 1991 dengue epidemic in Kaohsiung City. J Formosan Med Assoc 92: S39-S43.
17. Kouri GP, Guzman MG & Bravo JR (1987) Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans Roy Soc Trop Med Hyg 81: 821-823.
18. Kuberski T, Rosen L, Reed D & Mataika J (1997) Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. Am J Trop Med Hyg 26: 775-783.
19. Kurane I, Meager A & Ennis FA (1989) Dengue virus-specific human T cell clones. Serotype cross reactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med 170: 763-775.
20. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J & Ennis FA (1991) Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 88: 1473-1480.
21. Libraty DH, Endy TP, Houng HH et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
22. Liu JW, Khor BS, Lee CH, Chen RF & Yang KD (2003) Dengue hemorrhagic fever in Taiwan. Dengue Bull 27: 19-23.
23. Makino Y, Tadano M, Saito M, Maneekarn N, Sittisombut N, Sirisanthana V, Poneprasert B & Fukunaga T (1994) Studies on serological cross-reaction in sequential flavivirus infections. Microbiol Immunol 38: 951-955.
24. Morens DM (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
25. Morens DM, Halstead SB, Repik PM, Putvatana R & Raybourne N (1985) Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells. J Clin Microbiol 22: 250-254.
26. Murgue B, Roche C, Chungue E & Deparis X (2001) Prospective study of the duration and magnitude of viraemia in children hospitalized during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol 63: 29-34.
27. Mustafa AS, Elbishbishi EA, Agarwal R & Chaturvedi UC (2001) Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 30: 229-333.
28. Pacsa AS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R & Mustafa AS (2000) Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 28: 151-155.
29. Paludan SR, Lovmand J, Ellermann-Eriksen S & Mogensen SC (1997) Effect of IL-4 and IL-13 on IFN-gamma-induced production of nitric oxide in mouse macrophages infected with herpes simplex virus type 2. FEBS Lett 414: 61-64.
30. Payvandi F, Amrute S & Fitzgerald-Bocarsly P (1998) Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol 160: 5861-5868.
31. Perez AB, Garcia G, Sierra B et al. (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73: 230-234.
32. Pinheiro FP & Corber SJ (1997) Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Statist Quart 50: 161-169.
33. Rico-Hesse R, Harrison LM, Nisalak A, Vaughn DW, Kalayanarooj S, Green S, Rothman AL & Ennis FA (1998) Molecular evolution of dengue type 2 virus in Thailand. Am J Trop Med Hyg 58: 96-101.
34. Rosen L (1996) Dengue hemorrhagic fever. Bull Soc Pathol Exot 89: 91-94.
35. Sainz B Jr & Halford WP (2002) Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol 76: 11541-11550.
36. Sangkawibha N, Rojanasuphot S & Ahandrink S (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I: The 1980 outbreak. Am J Epidemiol 120: 653-661.
37. Singh J, Balakrishnan N, Bhardwaj M et al. (2000) Silent spread of dengue and dengue haemorrhagic fever to Coimbatore and Erode districts in Tamil Nadu, India, 1998: need for effective surveillance to monitor and control the disease. Epidemiol Infect 125: 195-200.
38. Vaughn DW, Green S, Kalayanarooj S et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
39. Wang WK, Chao DY, Kao CL,Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH & King CC (2003) High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305: 330-338.
40. Yang KD, Lee CS, Hwang KP, Chu ML & Shaio MF (1995) A model to study cytokine profiles in primary and heterologously secondary Dengue-2 virus infections. Acta Virol 39: 19-21.
41. Yang KD, Yeh WT & Shiao MF (2001) Antibody-dependent enhancement of DEN-2 infections involved in suppression of IFNγ production. J Med Virol 63: 150-157.
42. Zhao XX, Liao MJ & Rashidbaigi A (1998) Inhibitory effect of interleukin-10 on human leukocyte interferon-alpha production by Sendai virus. Cytokines Cell Mol Ther 4: 11-16.